Measles elimination efforts and 2008-2011 outbreak, France

Emerging Infectious Diseases

Volumn 19, Issue 3, 2013, Pages 357-364

  Antona, Denise ^a   Lévy Bruhl, Daniel ^a   Baudon, Claire ^a   Freymuth, François ^b   Lamy, Mathieu ^a   Maine, Catherine ^a   Floret, Daniel ^c   du Chatelet, Isabelle Parent ^a  

^a INSTITUT DE VEILLE SANITAIRE   (France)

^b CAEN UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DEATH; DISEASE SEVERITY; EPIDEMIC; FEMALE; FRANCE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VACCINATION; NUCLEOTIDE SEQUENCE; PNEUMONIA; PRESCHOOL CHILD; SCHOOL CHILD;

ADOLESCENTS; CHILDREN; ELIMINATION; EPIDEMIOLOGY; FRANCE; IMMUNIZATION; MEASLES; VACCINES; VIRUSES; YOUNG ADULTS;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; DISEASE OUTBREAKS; FEMALE; FRANCE; GENOTYPE; HUMANS; INFANT; MALE; MASS VACCINATION; MEASLES; MEASLES VACCINE; MORBILLIVIRUS; YOUNG ADULT;

EID: 84874255600     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1903.121360     Document Type: Article

References (24)

1. Ministère de la Santé et des Solidarités. Plan d'élimination de la rougeole et de la rubéole congénitale en France-2005-2010 [cited 2012 Sep 2]. http://www.sante.gouv.fr/IMG/pdf/plan_elimination_rougeole.pdf
2. Haut conseil de la santé publique. Le calendrier des vaccinations et les recommandations vaccinales 2011 selon l'avis du Haut Conseil de la santé publique. Bull Epidemiol Hebd. 2011;10-11:101-56 [cited 2012 Sep 2]. http://www.invs.sante.fr/content/download/4393/28810/version/4/file/beh_10_11_2011.pdf
3. Branchet R, Chauvin P, Flahault A. Measles: sub optimal situation in France. Euro Surveill. 2000;5:21-2.
4. Parent du Châtelet I, Antona D, Waku-Kouomou D, Freymuth F, Maine C, Lévy-Bruhl D. La rougeole en France en 2008: bilan de la déclaration obligatoire. Bull Epidemiol Hebd. 2009:39-40: 415-419 [cited 2012 Sep 2]. http://www.invs.sante.fr/beh/2009/39_40/beh_39_40_2009.pdf
5. Antona D, Baudon C, Freymuth F, Lamy M, Maine C, Parent du Chatelet I, et al. Measles in France [in French]. Med Sci (Paris). 2012;28:1003-7. http://dx.doi.org/10.1051/medsci/20122811023
6. Guthmann JP, Fonteneau L, Lévy-Bruhl D. Mesure de la couverture vaccinale en France. Sources de données et données actuelles. Saint-Maurice: Institut de veille sanitaire; 2012 [cited 2012 Sep 2]. http://www.invs.sante.fr/Dossiers-thematiques/Maladies-infectieuses/ Maladies-a-prevention-vaccinale/Couverture-vaccinale/Publications
7. Marin M, Nguyen HQ, Langidrik JR, Edwards R, Briand K, Papania MJ, et al. Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policy. Clin Infect Dis. 2006;42:315-9. http://dx.doi.org/10.1086/498902
8. Parent du Châtelet I, Antona D, Freymuth F, Muscat M, Halftermeyer-Zhou F, Maine C, et al. Spotlight on measles 2010: update on the ongoing measles outbreak in France, 2008-2010. Euro Surveill. 2010;15:19656.
9. Filia A, Brenna A, Pana A, Cavallaro GM, Massari M. Ciofi degli Atti ML. Health burden and economic impact of measles-related hospitalizations in Italy in 2002-2003. BMC Public Health. 2007;7:169. http://dx.doi.org/10.1186/1471-2458-7-169
10. Yasunaga H, Shi Y, Takeuchi M, Horiguchi H, Hashimoto H, Matsuda S, et al. Measles-related hospitalizations and complications in Japan, 2007-2008. Intern Med. 2010;49:1965-70. http://dx.doi.org/10.2169/internalmedicine.49.3843
11. Moren A, Drucker J, Lévy-Bruhl D. Efficacité vaccinale: mesures et contraintes méthodologiques. Cahiers Santé. 1994;4:221-5.
12. Brown KE, Mulders MN, Freymuth F, Santibanez S, Mosquera MM, Cordey S, et al. Appearance of a novel measles G3 strain in multiple European countries within a two month period, 2010. Euro Surveill. 2011;16:19852.
13. ECDC. European monthly measles monitoring (EMMO) 2012, Issue 8: 21 February 2012 [cited 2012 Sep 2]. http://www.ecdc.europa.eu/en/publications/Publications/SUR_EMMO_European-monthly-measles-monitoring-February-2012.pdf
14. Cottrell S, Roberts RJ. Measles outbreak in Europe. BMJ. 2011;342:d3724. http://dx.doi.org/10.1136/bmj.d3724
15. Steffens I, Martin R, Lopalco P. Spotlight on measles 2010: measles elimination in Europe-a new commitment to meet the goal by 2015. Euro Surveill. 2010;15:19749.
16. Muscat M. Who gets measles in Europe? J Infect Dis. 2011;204(Suppl 1):S353-65. http://dx.doi.org/10.1093/infdis/jir067
17. Centers for Disease Control and Prevention. Measles-United States, 2011. MMWR Morb Mortal Wkly Rep. 2012;61:253-7.
18. Lévy-Bruhl D, Maccario D, Richardson S, Guérin N. Modélisation de la rougeole en France et conséquences pour l'âge d'administration de la seconde vaccination rougeole-oreillons-rubéole. BEH. 1997,29:133-5 [cited 2012 Sep 2]. http://www.invs.sante.fr/beh/1997/9729/beh_29_1997.pdf
19. Bonmarin I, Levy-Bruhl D. Measles in France: the epidemiological impact of suboptimal immunisation coverage. Euro Surveill. 2002;7:55-60.
20. Lévy-Bruhl D, Pebody R, Veldhuijzen IK, Valenciano M, Osborne K. ESEN: a comparison of vaccination programmes. Part three: measles, mumps, and rubella. Euro Surveill. 1998;3:115-9.
21. Nicolay N, Lévy-Bruhl D, Fonteneau L, Jauffret-Roustide M. Vaccinations: perceptions et attitudes. Enquête Nicolle 2006. Saint Denis: Inpes, coll Etudes santé; 2008. p. 87-101.
22. Rotily M, Guagliardo V, Fontaine D, Garros B, Mayer C, Arrighi J, et al. Evaluation of measles, mumps, and rubella vaccine coverage in 3 years old children in 12 French counties. Time-trends and related factors [in French]. Rev Epidemiol Sante Publique. 2001;49:331-41.
23. Lévy-Bruhl D, Desenclos JC, Rebiere I, Drucker J. Central demyelinating disorders and hepatitis B vaccination: a risk-benefit approach for pre-adolescent vaccination in France. Vaccine. 2002;20:2065-71. http://dx.doi.org/10.1016/S0264-410X(02)00053-1
24. Lepoutre A, Antona D, Fonteneau L, Baudon C, Halftermeyer-Zhou F, Le Strat Y, et al. Enquête nationale de séroprévalence des maladies infectieuses 2009-2010, 1ers résultats. 12ème Journées Nationales d'Infectiologie, Toulouse 2011. Med Mal Infect. 2011;41(Suppl 1):H16.